<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
43624-043-01
</NDCCode>
<PackageDescription>
3 TRAY in 1 BOX (43624-043-01) / 104 VIAL in 1 TRAY / 20 mL in 1 VIAL
</PackageDescription>
<NDC11Code>
43624-0043-01
</NDC11Code>
<ProductNDC>
43624-043
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Polatuzumab Vedotin Lyophilized Vials 140 Mg
</NonProprietaryName>
<DosageFormName>
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20190610
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
BSP Pharmaceuticals S.p.A.
</LabelerName>
<SubstanceName>
POLATUZUMAB VEDOTIN
</SubstanceName>
<StrengthNumber>
140
</StrengthNumber>
<StrengthUnit>
mg/7.52mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2026-05-11
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
06-OCT-19
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>